Publication for KIF23 and KIF18A

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	KIF23	kinesin family member 23	9493			[link]
hsa	KIF18A	kinesin family member 18A	81930

Pubmed ID	Priority	Text
32322170	0.98	KIF18A, KIF18B, KIF20A, KIF20B, KIF22, KIF23, KIF24, KIF26B, KIF2C, KIF3B, KIF4A, KIFC1) using both TCGA-BRCA and matched GTEx-breast normal data (Tumor = 810; Normal = 291); *P < 0.05; **P < 0.001
	0.98	KIF18A, KIF18B, KIF20A, KIF20B, KIF22, KIF23, KIF24, KIF26B, KIF2C, KIF3B, KIF4A, KIFC1) significantly overexpressed in breast cancer (Fig. 1b, P < 0.001).
	0.98	KIF18A, KIF18B, KIF20A, KIF23, KIF2C, KIF4A, KIFC1) were found to be significantly related to worse outcomes regarding OS, RFS and DMFS, indicating that KIFs play important roles in breast cancer and hold the key to the prognosis of patients (Fig. 2a).
	0.95	KIF18A, KIF18B, KIF20A, KIF20B, KIF22, KIF23, KIF24, KIF26B, KIF2C, KIF3B, KIF4A, KIFC1) with survival analyses regarding OS, RFS and DMFS using chip-seq data.
	0.88	KIF18A, KIF18B, KIF20A, KIF23, KIF2C, KIF4A, KIFC1).
	0.77	KIF18A, KIF18B, KIF20A, KIF23, KIF2C, KIF4A, KIFC1) significantly correlated with worse OS, relapse-free survival (RFS) and distant metastasis-free survival (DMFS) of breast cancer.
	0.63	KIF18A, KIF18B, KIF20A, KIF23, KIF2C, KIF4A, KIFC1) that demonstrated significant prognostic value in breast cancer were enrolled for LASSO regression to construct a KIFs-based risk score for prediction of OS in breast cancer.
	0.52	KIF18A, KIF18B, KIF20A, KIF23, KIF2C, KIF4A, KIFC1) significantly correlated with worse OS, RFS and DMFS of breast cancer, indicating efficient biomarkers for predicting the prognosis of breast cancer.
30872592	0.98	KIF18A [HR]: 1.38 [95% CI 1.02-1.87], KIF23 [HR] 1.31 [95% CI 1.05-1.62], KIF9 [HR] 2.53 [95% CI 1.61-3.99]).
	0.93	KIF18A, and KIF23 were elevated in LGG patients with a higher histological grade and astrocytoma histologic type than in those with a lower histological grade and histologic type, including oligoastrocytoma and oligodendroglioma.
	0.84	KIF18A [HR]: 3.09 [95% CI 2.17-4.4], KIF23 [HR] 3.62 [95% CI 2.52-5.21], KIF9 [HR] 2.17 [95% CI 1.39-3.41]).
	0.65	KIF18A, and KIF23 alterations showed a poorer prognosis than those lacking these alterations in LGG.
21390237	0.98	Kif18a, Kif22, Kif4), segregation (Aspm Cenpe, Ckap2, Incenp, Jub, Kif20a, Kif23, Lats2, Prc1), and/or cytokinesis (Incenp, Kif20a, Kif23, Prc1) (Table 4).
23554969	0.98	KIF18A, KIF20B, and KIF23) that encode proteins involved in microtubule-based cellular movement showed significantly lower levels of expression in the DD patient fibroblasts (Figure S1).
30940825	0.98	KIF18A, KIF23, KIF2C, KIFC1, and MARK2.
30906836	0.95	KIF23, RACGAP1, CCNB2, MLF1IP, AURKA, TOP2A, CENPA, CDK1, NCAPG, NDC80, NEK2, KIF11, KIF4A, BUB1, PRC1, CDCA8, CCNA2, CDC20, BIRC5, BUB1B, MAD2L1, ZWILCH, CKAP5, KIF18A, KIF2C, CENPE, CENPF, CENPK, KIF20A, CCNB1 are the genes found in the top cluster with high interaction.
23264559	0.94	KIF18A, KIF20A, KIF20B, KIF23, KIFC1, KIFC2).
30813560	0.94	KIF18A and KIF23 does not (Figure 5C).
30593585	0.93	KIF23 (F), KIF11 (G), KIF14 (H), KIF15 (I), KIF18A (J), and KIF26B (K).
21386884	0.92	KIF23, PRC1, RACGAP1, ASPM, KIF18A and PLK1) contributes to the predictive power of the DM signature significantly more than the other genes.
32063710	0.81	KIF18A, KNSTRN, ANLN, NEIL3, KIF23, HELLS, E2F7, DEPDC1, ERCC6L, PARPBP, and FBXO5), as shown in Figure 1C.
28099485	0.69	KIF18A, KIF20A, KIF23) modulated by AS03 at day 3 in NK more likely play a role in cell division, as multiple modules of proliferation- and cell division-related genes were identified in this cell type at this time point.